| Virginia Justince, RN | |
|
250 North Ave, Athens, GA 30601-2244 | |
| (706) 542-9739 | |
| Not Available |
| Full Name | Virginia Justince |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 250 North Ave, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841261575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN046626 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Justince, RN 250 North Ave, Athens, GA 30601-2244 Ph: (706) 542-9700 | Virginia Justince, RN 250 North Ave, Athens, GA 30601-2244 Ph: (706) 542-9739 |
News Archive
Diminished bone density is common among menopausal women and raises their risk of osteoporosis, bone fractures and subsequent complications. Research has traditionally focused on therapies that seek to maintain the level of estrogen in the body. This hormone seems to sustain bone health, but it drops to an extremely low level during and after menopause.
VIVUS, Inc. today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity. The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital, the nation's leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases.
A comprehensive Argentinean epidemiological study reveals the staggering costs of osteoporosis in the country.
› Verified 5 days ago
Fanie Wehmanen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-612-6995 Fax: 706-369-6328 | |
Janet Robison Avant, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9739 | |
Marjorie Spencer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mr. Vito Cortese Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 855-333-9544 | |
Richard Cereneche, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 195 Miles St, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mary Donna Hall, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-0333 Fax: 706-542-9693 | |
Tiny Stephens, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 675 College Ave, Athens, GA 30601 Phone: 706-546-5526 |